Geneos Wealth Management’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233K Hold
9,620
– – ﹤0.01% 941
2026
Q1
$233K Hold
9,620
– – 0.01% 915
2025
Q4
$234K Hold
9,620
– – 0.01% 877
2025
Q3
$234K Hold
9,620
– – 0.01% 851
2025
Q2
$233K Buy
9,620
+5,400
+128% +$130K 0.01% 937
2025
Q1
$102K Buy
4,220
+820
+24% +$19.7K ﹤0.01% 1155
2024
Q4
$81.5K Hold
3,400
– – ﹤0.01% 1139
2024
Q3
$82.9K Hold
3,400
– – ﹤0.01% 1020
2024
Q2
$80.7K Hold
3,400
– – ﹤0.01% 931
2024
Q1
$80.9K Hold
3,400
– – ﹤0.01% 912
2023
Q4
$81.4K Hold
3,400
– – ﹤0.01% 898
2023
Q3
$78.7K Hold
3,400
– – ﹤0.01% 942
2023
Q2
$79.8K Hold
3,400
– – ﹤0.01% 940
2023
Q1
$81K Hold
3,400
– – ﹤0.01% 913
2022
Q4
$79.5K Hold
3,400
– – ﹤0.01% 892
2022
Q3
$78K Hold
3,400
– – 0.01% 869
2022
Q2
$81K Hold
3,400
– – ﹤0.01% 1095
2022
Q1
$84K Hold
3,400
– – ﹤0.01% 1154
2021
Q4
$90K Sell
3,400
-600
-15% -$16K ﹤0.01% 1211
2021
Q3
$108K Hold
4,000
– – ﹤0.01% 1144
2021
Q2
$108K Hold
4,000
– – ﹤0.01% 1133
2021
Q1
$107K Hold
4,000
– – ﹤0.01% 1274
2020
Q4
$107K Hold
4,000
– – ﹤0.01% 1120
2020
Q3
$108K Hold
4,000
– – 0.01% 917
2020
Q2
$107K Hold
4,000
– – 0.01% 892
2020
Q1
$96K Buy
4,000
+700
+21% +$18.1K 0.01% 846
2019
Q4
$85K Buy
3,300
+2,600
+371% +$67.3K ﹤0.01% 1008
2019
Q3
$18K Buy
+700
New +$18K ﹤0.01% 1654

Other funds holding IBDS

Geneos Wealth Management's IBDS Position: Q2 2026 in Review

Geneos Wealth Management held its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) position steady in Q2 2026 at 9,620 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Geneos Wealth Management first reported a position in IBDS in Q3 2019 and has held it in 28 quarters since. The position peaked at $234K in Q3 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Geneos Wealth Management held 9,620 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $233K as of Q2 2026.
  • Geneos Wealth Management left its iShares iBonds Dec 2027 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #941 holding.
  • Geneos Wealth Management first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2019 and has held it in 28 quarters since.
  • Geneos Wealth Management's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $234K in Q3 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.